Search

everythinglearnresearchcommunity

for

Search:↓

Compound 4 is a promising treatment for hair loss with low toxicity.

24-Hydroxycholesterol reduces DHT formation in brain cancer cells, linking cholesterol and hormone metabolism.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Mitotane changes steroid breakdown, affecting cortisol availability.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Testosterone and some of its forms can strongly stimulate oil gland growth in skin.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

A young tapir with a rare skin condition improved after treatment with wound cleaning, cream, and oral medication.

Gut microbiota and metabolic pathways may play a key role in PCOS development.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Alopecia X in dogs is a cosmetic issue, not a hormonal disorder, and harmful treatments should be avoided.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Changing neuroactive steroid levels early in life can affect how adult rats respond to alcohol's stimulating effects.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

Regulating certain sex hormones may help delay facial aging.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

New compounds show promise as nonsteroidal treatments for hair loss.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.